
Our team consists of highly experienced professionals with deep knowledge in preclinical research, ensuring quality results that align with the latest industry standards and accelerate the drug development process.
We tailor our preclinical contract research services to fit your specific project requirements, providing flexibility and focused support to meet diverse research and development needs efficiently.
KCI Biotech adheres to GLP principles and maintains AAALAC accreditation, guaranteeing high-quality research standards in all projects and instilling confidence in our clients regarding study integrity.
We offer over 500 animal disease models across various species, allowing for extensive pharmacological studies and a robust foundation for effective preclinical evaluations and drug testing.





Comprehensive preclinical drug development and service platform
Building A2, No, 8 Yanghua road, Suzhou industrial Park, Suzhou.P.R, china